Directive 2001/83/EC of the European Parliament and of the… Article 74

Article 74

On the occasion of the five-yearly renewal of the marketing authorization or when new facts are brought to their notice, the competent authorities shall examine and, as appropriate, amend the classification of a medicinal product, by applying the criteria listed in Article 71.

Read the full instrument → · Read this in context: TITLE VI — CLASSIFICATION OF MEDICINAL PRODUCTS →

Other provisions in TITLE VI — CLASSIFICATION OF MEDICINAL PRODUCTS

Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗ · Data as of 2026-07-04

CitationArticle 74 of Directive 2001/83/EC of the European Parliament and of the… (LawPlayer, data as of 2026-07-04)

What to look at next

Directive 2001/83/EC of the European Parliament and of the…, full textChapter navigation and full text, so you can read this section in contextEuropean Union legislation EU Legal Acts by type and yearGrouped by instrument type and year of enactment, so you can find others of the same kindBrowse by type and year TITLE VI — CLASSIFICATION OF MEDICINAL PRODUCTS — read this in contextThe surrounding text of the act in order, so you can see what comes before and afterChapters and sections